The quantity of prostate-specific antigen (PSA) in your blood is determined by a PSA test. The prostate is regarded as a male reproductive system internal organ. It produces a liquid that is crucial for production and is situated below the bladder. The prostate produces PSA, a chemical. In general, men’s blood PSA levels are low. The most prevalent non-skin disease affecting American men, prostate cancer, may be growing and may be indicated by a high PSA test. High PSA levels can also indicate benign prostatic conditions, such as illness or benign prostatic hyperplasia, which is a noncancerous growth of the prostate.
Prostate cancer is diagnosed via a PSA test. A screening test looks for an illness or disease in its early stages, when it is still curable. The American Cancer Society and the Centers for Disease Control and Prevention (CDC), two major health organisations, have different opinions on how best to use the PSA test for cancer screening.
Global Prostate Specific Antigen (PSA) Testing Market size was $3.12 billion in 2021, and is expected to grow at a value of more than $5.88 billion by 2030, with a growing CAGR (Compound annual growth rate) of over 11% from 2022 to 2030.
Prostate Specific Antigen (PSA) Testing is a type of protein that is primarily released by epithelial prostatic cells and is a useful tumour marker for prostate cancer. Despite the fact that it is not a prostate-specific molecule, its higher level in blood serum is used to screen men for prostate cancer. PSA levels above a certain threshold are linked to prostatitis, or inflammation of the prostate gland, or to a benign form of prostatic hyperplasia. PSA testing is used to screen asymptomatic men for prostate cancer in conjunction with a digital rectal exam (DRE). PSA screening has grown in favour among clinicians and healthcare providers as a way to detect suspected cases of prostate cancer and assist them figure out what’s wrong.
Global Prostate Specific Antigen (PSA) Testing Market: Segmentations
Key Players
Bayer AG.
Beckman Coulter Inc.
GE Healthcare
GlaxoSmithKline plc.
Novartis Pharma AG.
UroLogix Inc.
Bristol – Myers Squibb Company
AstraZeneca plc.
MDx Health
Myriad Genetics Inc
- Hoffman-La Roche AG
Siemens Healthineers AG
OPKO Health Inc.
Genomic Health
DiaSorin
Roche
PerkinElmer
Tosoh
Ortho Clinical
Fujirebio
Mediwatch (LABORIE)
BodiTech
Prostate Specific Antigen (PSA) Testing Market by test procedure
- Preliminary Tests
- Confirmatory Tests
Prostate Specific Antigen (PSA) Testing Market by test type:
- Total Prostate Specific Angiten Test (tPSA)
- Complex Prostate Specific Antigen Test (cPSA)
- Free Prostate Specific Antigen Test (fPSA)
- Prostate Specific Antigen Reverse Transcription Polymerase Chain Reaction Test (PSA RT-PCR)
- PCA3Test
- Trans-rectal Ultrasound
- Biopsy
Among these, the biopsy segment is anticipated to grow significantly over the forecast period owing to rising prevalence of cancer across the globe.
Prostate Specific Antigen (PSA) Testing Market by assays type:
- Radioimmunoassay (RIA)
- Enzyme immunoassay (EIA)
Prostate Specific Antigen (PSA) Testing Market by application:
- Screening
- Post-treatment monitoring
- Others
Among these, post treatment monitoring segment is anticipated to gain traction over the forecast duration due to rising concerns about the after effect of medical treatment procedures like surgeries.
Purchase Global Prostate Specific Antigen (PSA) Testings Market Research Report:- https://wemarketresearch.com/purchase/prostate-specific-antigen-(psa)-testing-market/28/?license=single
Key Questions answered in the India Prostate Specific Antigen (PSA) Testing Market Report are:
- Which product segment grabbed the largest share in this market?
- How is the competitive scenario of this market?
- Which are the key factors aiding this market growth?
- Which region holds the maximum share in this market?
- What will be the CAGR of this market during the forecast period?
- Which application segment emerged as the leading segment in this market?
- Which are the prominent players in this market?
- What key trends are likely to emerge in this market in the coming years?
- What will be the India Prostate Specific Antigen (PSA) Testing market size by 2028?
- Which company held the largest share in the India Prostate Specific Antigen (PSA) Testing market?
About We Market Research
WE MARKET RESEARCH is an established market analytics and research firm with a domain experience sprawling across different industries. We have been working on multi-county market studies right from our inception. Over the time, from our existence, we have gained laurels for our deep rooted market studies and insightful analysis of different markets.
Our strategic market analysis and capability to comprehend deep cultural, conceptual and social aspects of various tangled markets has helped us make a mark for ourselves in the industry. WE MARKET RESEARCH is a frontrunner in helping numerous companies; both regional and international to successfully achieve their business goals based on our in-depth market analysis. Moreover, we are also capable of devising market strategies that ensure guaranteed customer bases for our clients.
Contact Us:
We Market Research
Phone: +1(929)-450-2887
Email: [email protected]
Web: https://wemarketresearch.com
